Gelatinase and Vulnerability of Atherosclerotic Plaque
- PMID: 27237102
- PMCID: PMC7399262
- DOI: 10.5551/jat.ED048
Gelatinase and Vulnerability of Atherosclerotic Plaque
Conflict of interest statement
None.
Similar articles
-
Involvement of Angiotensin II Type 1 and 2 Receptors in Gelatinase Regulation in Human Carotid Atheroma in vitro.J Atheroscler Thromb. 2016 Jul 1;23(7):773-91. doi: 10.5551/jat.31401. Epub 2016 Mar 5. J Atheroscler Thromb. 2016. PMID: 26947595 Free PMC article.
-
Impaired fibrous repair: a possible contributor to atherosclerotic plaque vulnerability in patients with type II diabetes.Arterioscler Thromb Vasc Biol. 2014 Sep;34(9):2143-50. doi: 10.1161/ATVBAHA.114.303414. Epub 2014 Jul 17. Arterioscler Thromb Vasc Biol. 2014. PMID: 25035341
-
[Relationship between atherosclerotic plaque progression, vulnerability and vascular remodeling].Nihon Rinsho. 2011 Sep;69 Suppl 7:113-6. Nihon Rinsho. 2011. PMID: 22518975 Japanese. No abstract available.
-
Plaque angiogenesis and its relation to inflammation and atherosclerotic plaque destabilization.Curr Opin Lipidol. 2016 Oct;27(5):499-506. doi: 10.1097/MOL.0000000000000339. Curr Opin Lipidol. 2016. PMID: 27472406 Review.
-
Pathophysiology of Atherosclerotic Plaque Development.Cardiovasc Hematol Agents Med Chem. 2015;13(1):10-3. doi: 10.2174/1871525713666141218163425. Cardiovasc Hematol Agents Med Chem. 2015. PMID: 25544119 Review.
Cited by
-
Plaque-targeted, proteolysis-resistant, activatable and MRI-visible nano-GLP-1 receptor agonist targets smooth muscle cell differentiation in atherosclerosis.Theranostics. 2022 Mar 6;12(6):2741-2757. doi: 10.7150/thno.66456. eCollection 2022. Theranostics. 2022. PMID: 35401813 Free PMC article.
References
-
- Adiguzel E, Ahmad PJ, Franco C, Bendeck MP. Collagens in the progression and complications of atherosclerosis. Vasc Med. 2009; 14: 73-89.2 - PubMed
-
- Hopps E, Caimi G. Matrix metalloproteases as a pharmacological target in cardiovascular diseases. Eur Rev Med Pharmacol Sci. 2015; 19: 2583-2589 - PubMed
-
- Newby AC. Matrix metalloproteinase inhibition therapy for vascular diseases. Vascul Pharmacol. 2012; 56: 232-244 - PubMed
-
- Newby AC. Metalloproteinases promote plaque rupture and myocardial infarction: A persuasive concept waiting for clinical translation. Matrix Biol. 2015; 44-46: 157-166 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources